EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity

Joud Mohammed AlKhalifah iD, Waleed Seddiq iD, Mohammed Abdullah Alshehri, Abdulkarim Alhetheel, Ahmed Albarrag, Sultan Ayoub Meo iD, Jaffar A Al-Tawfiq iD, Mazin Barry iD

Vaccines · 26.02.2023 · 11 (3) · 552

DOI: 10.3390/vaccines11030552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 26.02.2023. Verfasst von Joud Mohammed AlKhalifah und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a considerable threat to public health and global economies. SARS-CoV-2 has largely affected a vast world population and was declared a COVID-19 pandemic outbreak, with a substantial surge of SARS-CoV-2 infection affecting all aspects of the virus’ natural course of infection and immunity. The cross-reactivity between the different coronaviruses is still a knowledge gap in the understanding of the SARS-CoV-2 virus. This study aimed to investigate the impact of MERS-CoV and SARS-CoV-2 viral infections on immunoglobulin-IgG cross-reactivity. Our retrospective cohort study hypothesized the possible reactivation of immunity in individuals with a history of infection to Middle East Respiratory Syndrome coronavirus (MERS-CoV) when infected with SARS-CoV-2. The total number of participants included was 34; among them, 22 (64.7%) were males, and 12 (35.29%) were females. The mean age of the participants was 40.3 ± 12.9 years. This study compared immunoglobulin (IgG) levels against SARS-CoV-2 and MERS-CoV across various groups with various histories of infection. The results showed that a reactive borderline IgG against both MERS-CoV and SARS-CoV-2 in participants with past infection to both viruses was 40% compared with 37.5% among those with past infection with MERS-CoV alone. Our study results establish that individuals infected with both SARS-CoV-2 and MERS-CoV showed higher MERS-CoV IgG levels compared with those of individuals infected previously with MERS-CoV alone and compared with those of individuals in the control. The results further highlight cross-adaptive immunity between MERS-CoV and SARS-CoV. Our study concludes that individuals with previous infections with both MERS-CoV and SARS-CoV-2 showed significantly higher MERS-CoV IgG levels compared with those of individuals infected only with MERS-CoV and compared with those of individuals in the control, suggesting cross-adaptive immunity between MERS-CoV and SARS-CoV.

Schlagwörter

Stichwörter der Autor:innen

MERS-CoVSARS-CoV-2coronavirusescross-immunityimmunity

Autor:innen und Institutionen

  • College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
  • Center for Stem Cell and Translational Immunotherapy (CSTI), Harvard Medical School, Boston, MA 02115, USA.
  • Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Department of Pathology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
  • Department of Physiology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

ORCID-Profile: Joud Mohammed AlKhalifah, Waleed Seddiq, Sultan Ayoub Meo, Jaffar A Al-Tawfiq, Mazin Barry

Förderung

  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

AlKhalifah, J. M., Seddiq, W., Alshehri, M. A., Alhetheel, A., Albarrag, A., Meo, S. A., Al-Tawfiq, J. A., & Barry, M. (2023). Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity. Vaccines, 11(3), 552. https://doi.org/10.3390/vaccines11030552

Vancouver

AlKhalifah JM, Seddiq W, Alshehri MA, Alhetheel A, Albarrag A, Meo SA, et al. Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity. Vaccines. 2023;11(3):552. doi:10.3390/vaccines11030552

BibTeX
@article{AlKhalifah2023,
  author = {AlKhalifah, Joud Mohammed and Seddiq, Waleed and Alshehri, Mohammed Abdullah and Alhetheel, Abdulkarim and Albarrag, Ahmed and Meo, Sultan Ayoub and Al-Tawfiq, Jaffar A and Barry, Mazin},
  title = {Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {3},
  pages = {552},
  doi = {10.3390/vaccines11030552}
}
Kostenlos starten →